A- A A+

Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada. 

Cassie R, Hayashi K, DeBeck K, Milloy MJ, Cui Z, Strike C, West J, Kennedy MC. 

Harm Reduct J. 2022 Nov 18;19(1):126. doi: 10.1186/s12954-022-00712-7. PMID: 36401299; PMCID: PMC9675060.


Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study. 

Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Hyshka E, Martin NK, Larney S. 

Int J Drug Policy. 2022 Oct 17;110:103894. doi: 10.1016/j.drugpo.2022.103894. Epub ahead of print. PMID: 36308892; PMCID: PMC9574459.


The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals. 

Bosch-Arís M, Gasulla L, de Gispert T, Segura L, Colom J. 

Harm Reduct J. 2022 Oct 26;19(1):118. doi: 10.1186/s12954-022-00699-1. PMID: 36289531; PMCID: PMC9596343.


Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews. 

Carry M, Bixler D, Weng MK, Doshani M, Roberts E, Montgomery MP. Supporting 

Harm Reduct J. 2022 Sep 1;19(1):100. doi: 10.1186/s12954-022-00681-x. PMID: 36050735; PMCID: PMC9435406.


Supporting Self-isolation for COVID-19 With "Risk Mitigation" Prescribing and Housing Supports for People Who Use Drugs: A Case Report. 

Hong RH, Brar R, Fairbairn N. 

J Addict Med. 2022 Sep-Oct 01;16(5):592-594. doi: 10.1097/ADM.0000000000000954. Epub 2022 Feb 10. PMID: 35149612; PMCID: PMC9531921.


Australien. Changes in the use of Melbourne’s Medically Supervised Injecting Room (MSIR) over the COVID-19 pandemic 

The Illicit Drug Reporting System (IDRS) is a national drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and form part of Drug Trends. 

Supervised injecting facilities (SIFs) have been shown to reduce overdose-related morbidity and mortality, drug-related risk behaviors, and to improve public amenity.  

In this bulletin, we update findings from a previous IDRS Bulletin that included information on the use of the North Richmond MSIR in 2019 to examine responses to the 2020 and 2021 IDRS surveys of people who inject drugs in order to examine any changes in MSIR use evident in the Melbourne IDRS samples over the COVID-19 pandemic. (UNSW, NDARC, Australien, August 2022)


Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. 

Narasimha VL, Butner J, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, Kouimtsidis C, Baldacchino A, Arunogiri S. 

BJPsych Int. 2022 Aug;19(3):66-69. doi: 10.1192/bji.2022.1. PMID: 36287782; PMCID: PMC9540565.


Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. 

Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN. 

Int J Drug Policy. 2022 Nov;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub 2022 Aug 10. PMID: 35977459; PMCID: PMC9364718.


Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia. 

O'Keefe D, Livingston M, Cossar RD, Kerr P, Jacka D, Dietze P. 

Harm Reduct J. 2022 Sep 7;19(1):101. doi: 10.1186/s12954-022-00683-9. PMID: 36071500; PMCID: PMC9449958.


COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services. 

Perri M, Schmidt RA, Guta A, Kaminski N, Rudzinski K, Strike C. 

Int J Drug Policy. 2022 Aug 8;108:103815. doi: 10.1016/j.drugpo.2022.103815. Epub ahead of print. PMID: 35969920; PMCID: PMC9359504.


Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic. 

Chieh K, Patel I, Walter L, Li L. 

Harm Reduct J. 2022 Jul 26;19(1):84. doi: 10.1186/s12954-022-00667-9. PMID: 35883136; PMCID: PMC9321310.


Perceptions of Homeless Adults and Their Providers on Coping With the Impact of COVID-19 Pandemic on Mental Health, Substance Use, and Harm Reduction Services. 

Nyamathi AM, Gelberg L, Lee D, Arce N, Patten-Jones A, Yadav K, Goodwine M, Alikhani M, Yao M, Chang AH, Salem BE. 

Glob Qual Nurs Res. 2022 Jul 27;9:23333936221108712. doi: 10.1177/23333936221108712. PMID: 35912133; PMCID: PMC9335488.


The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19. 

McCrae K, Glegg S, Goyer MÉ, Le Foll B, Brar R, Sutherland C, Fairbairn N. 

Harm Reduct J. 2022 Jul 14;19(1):77. doi: 10.1186/s12954-022-00657-x. PMID: 35836189; PMCID: PMC9281344.


Kanada. There has been a big spike in homeless deaths in Toronto and other cities. The reasons go beyond a toxic drug supply

The cost of living, a housing crisis and COVID are factors. “People who have been invisible to society forever also died invisibly.”(Toronto Star, Kanada, 14.07.2022)


A rapid assessment of take-home naloxone provision during COVID-19 in Europe

Rebecca McDonald, Desiree Eide, Katri Abel-Ollo, Lee Barnsdale, Ben Carter, Thomas Clausen, Ed Day, Francina Fonseca, Elin Holmén, Kirsten Horsburgh, Mike Kelleher, Martin Kåberg, Martin Ladenhauf, Andrew McAuley, Nicola Metrebian, Joanne Neale, Stephen Parkin, Kevin Ratcliffe, Chris Rintoul, Josie Smith, Viktorija Stifanoviciute, Marta Torrens, Henrik Thiesen, John Strang,

International Journal of Drug Policy, Available online 1 July 2022, 103787, doi.org/10.1016/j.drugpo.2022.103787


“COVID knocked me straight into the dirt”: perspectives from people experiencing homelessness on the impacts of the COVID-19 pandemic. 

Rodriguez, N.M., Martinez, R.G., Ziolkowski, R. et al.

BMC Public Health 22, 1327 (2022). https://doi.org/10.1186/s12889-022-13748-y


Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada. 

Feder KA, Choi J, Schluth CG, Hayashi K, DeBeck K, Milloy MJ, Kirk GD, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Genberg BL. 

Drug Alcohol Depend. 2022 Jun 24:109544. doi: 10.1016/j.drugalcdep.2022.109544. Epub ahead of print. PMID: 35779987; PMCID: PMC9225925.


"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada. 

Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N. 

Int J Drug Policy. 2022 Jun 6;106:103742. doi: 10.1016/j.drugpo.2022.103742. Epub ahead of print. PMID: 35679695; PMCID: PMC9170132.


Vaccination and Communicable Disease Testing Services' Integration Within a Syringe Services Program: A Program Brief. 

Heidari O, Meyer D, O'Conor KJ, Cargill V, Patch M, Farley JE. COVID-19 

J Assoc Nurses AIDS Care. 2022 May-Jun 01;33(3):348-352. doi: 10.1097/JNC.0000000000000322. Epub 2022 Jan 12. PMID: 35025822.


Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. 

Brothers TD, Leaman M, Bonn M, Lewer D, Atkinson J, Fraser J, Gillis A, Gniewek M, Hawker L, Hayman H, Jorna P, Martell D, O'Donnell T, Rivers-Bowerman H, Genge L. 

Drug Alcohol Depend. 2022 Apr 7;235:109440. doi: 10.1016/j.drugalcdep.2022.109440. Epub ahead of print. PMID: 35461084; PMCID: PMC8988445.


The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. 

Lew B, Bodkin C, Lennox R, O'Shea T, Wiwcharuk G, Turner S. 

Harm Reduct J. 2022 Mar 21;19(1):29. doi: 10.1186/s12954-022-00614-8. PMID: 35313903.


Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. 

Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC. 

Drug Alcohol Depend. 2022 Mar 1;232:109323. doi: 10.1016/j.drugalcdep.2022.109323. Epub 2022 Jan 20. PMID: 35124386; PMCID: PMC8772135.


Kanada. How Halifax’s Safe Supply Hotels Brought Hope in the Early Pandemic

Early in the COVID-19 pandemic, in April 2020, there was a confirmed case at a pop-up shelter in Halifax, Nova Scotia. The unhoused residents—initially around 35 people, including some of the city’s most marginalized people who use drugs—were then moved into a fancy hotel in the city center to isolate.

Everything was such a mess at the time, much like it still is now. But a group of caring health care practitioners, including doctors, nurses, pharmacists, researchers, and harm reduction workers, took on the task of providing a safe supply of drugs to the people forced into the hotel. (Filter, 09.02.2022)


The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19. 

Carroll, J.J., Mackin, S., Schmidt, C. et al.

Harm Reduct J 19, 9 (2022). doi.org/10.1186/s12954-022-00590-z


Assessment of a Hotel-Based Protective Housing Program for Incidence of SARS-CoV-2 Infection and Management of Chronic Illness Among Persons Experiencing Homelessness. 

Huggett TD, Tung EL, Cunningham M, Ghinai I, Duncan HL, McCauley ME, Detmer WM. 

JAMA Netw Open. 2021 Dec 1;4(12):e2138464. doi: 10.1001/jamanetworkopen.2021.38464. PMID: 34902035.


Harm reduction must be recognised an essential public health intervention during crises. 

Csák, R., Shirley-Beavan, S., McHenry, A.E. et al. 

Harm Reduct J 18, 128 (2021). doi.org/10.1186/s12954-021-00573-6


Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another. 

Daskalakis G, Cid A, Grindrod K, Beazely MA. 

Pharmacy (Basel). 2021 Jul 23;9(3):129. doi: 10.3390/pharmacy9030129. PMID: 34449716; PMCID: PMC8396297.


Kanada. Overdose Prevention During a Pandemic

As the COVID-19 pandemic continues to present new challenges, historic, and systemic oppressors experienced by PWUD have only become more exacerbated. PWUD were already experiencing a lack of resources, lack of funding, and neglect by the health care system. In the context of a global pandemic, these inequities have driven up risk for PWUD, and it is paramount that we capture this experience to prevent history from repeating itself.

Therefore, the Canadian Association of People who Use Drugs collected data and held focus groups with our members to gain insight into the collateral impacts of COVID-19, as it relates specifically to overdose prevention services. (Canadian Association of People who Use Drugs, 02.07.2021)


Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. 

Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, Prohaska SM, LaKosky PA, Asher AK, Broz D, Jarlais DCD, Williams EC, Glick SN. 

AIDS Behav. 2021 Jun 10:1–12. doi: 10.1007/s10461-021-03332-7. Epub ahead of print. PMID: 34110506; PMCID: PMC8190167.


USA. Harm Reduction Is the Best Approach for COVID and Drug Addiction

In both cases, harm reduction is a better strategy than draconian rules that feel virtuous but don't actually work. (Scientific American, USA, 07.07.2021)